Skip to Content
Contact
☰
Site - Header Menu
About
Mission & Vision
Management Team
Board of Directors
Collaborations & Partnerships
Science
Epigenetic Scientific Platform
Preclinical Discovery Programs
Publications & Presentations
Clinical Development
Clinical Programs
Clinical Trials
Expanded Access Policy
Investigator Sponsored Trials
Medical Education & Sponsorship
Medicines
Investors & Media
Overview
Press Releases
Events & Presentations
Financial Information
SEC Filings
Quarterly Results
Annual Report & Proxy
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Corporate Governance
Management
Board of Directors
Committee Composition
Corporate Governance Documents
Resources
Careers
Investors & Media
Site - Investor Relations
Overview
Press Releases
Events & Presentations
Financial Information
SEC Filings
Quarterly Results
Annual Report & Proxy
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Corporate Governance
Management
Board of Directors
Committee Composition
Corporate Governance Documents
Resources
Investor FAQs
Contact
Annual Report & Proxy
Annual Report & Proxy
2021 Annual Report
1.7 MB
2022 Proxy Statement
413.3 KB
Site - Investor Relations
Overview
Press Releases
Events & Presentations
Financial Information
SEC Filings
Quarterly Results
Annual Report & Proxy
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Corporate Governance
Management
Board of Directors
Committee Composition
Corporate Governance Documents
Resources
Investor FAQs
Contact
Site - Shareholder Tools
Print Page
Email Alerts
Please ensure Javascript is enabled for purposes of
website accessibility
